Par Eric Hachulla (Lille) Article commenté : Prevention of vascular damage in scleroderma and autoimmune Raynaud’s phenomenon. A multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril. Gliddon AE et al. Arthritis Rheum 2007;56:3837-46 ► Retrouvez l’abstract en...